The class of 2019: A student’s perspective on all things pharma

We were keen to get a student’s perspective on the pharmaceutical industry, and in particular what was being taught in universities regarding patient-centred thinking. So we interviewed Raya Koldova, and here’s what she said… Where and what are you studying? I am currently studying for a Bachelor’s degree in Biochemistry and Pharmacology at the University…

ISMPP report the results of their lay summaries poll

ISMPP have presented the results of their poll into whether pharmaceutical companies will allocate internal resources to the development of lay summaries. Of 240 responses, 144 (60%) said ‘yes’. 8.8% reportd that they were unsure. Presumably this means that the remaining 31.3% will outsource the development of their lay summaries? Results available here

EMA update on Clinical Trials Information System

The European Medicines Agency’s (EMA) Management Board held its first meeting in Amsterdam on 21 March.  In meeting highlights released 22 March,  EMA provided the following update on the Clinical Trials Information System (CTIS): The Board was updated on the status of the ongoing development of the Clinical Trials Information System (CTIS – formerly the EU clinical trial portal…

UK Government position on clinical trial transparency

The UK government issued a policy paper on 22 February to improve clinical trials transparency in response to 10 recommendations a House of Commons Science and Technology committee report issued in October 2018. Importantly, in relation to lay summaries of clinical trials, the response to recommendation 1 states: ‘In the event of a negotiated agreement…

4th Annual Lay Summaries Summit 2019

Registration is now open for the 4th Annual Lay Summaries Summit, which will be held in Philadelphia on 25 and 26 September 2019. The agenda and speakers have yet to be announced. Lay Summaries Ltd look forward to being there!

Lay summary barometer

We’re running a survey to assess the awareness and preparedness of pharmaceutical companies to meet the impending regulatory change requiring trial sponsors to provide a summary of trial results understandable to a lay audience within 1 year of trial end. So far the average time to complete the survey is 1 minute 34 seconds! So…